This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

ERBA Diagnostics Inc (ERB)

AMEX: Health Care

Company Cash Flow
Dec 2014 Dec 2013 Dec 2012 Dec 2011
Cash Flow From Operating Activities
Net Income (Loss) 449.61K 675.83K -1.55M -3.30M
Operating Gains/Losses 0.00 0.00 0.00 0.00
Extraordinary Gains / Losses 0.00 0.00 0.00 0.00
(Increase) Decrease In Receivables -720.46K -830.24K 783.02K -995.44K
(Increase) Decrease in Inventories -290.47K -584.38K -179.13K 135.85K
(Increase) Decrease In Other Current Assets -652.39K -235.72K -126.03K -85.63K
(Decrease) Increase In Payables -159.07K -1.19M -116.95K -22.23K
(Decrease) Increase In Other Current Liabilities 0.00 0.00 0.00 0.00
(Increase) Decrease In Other Working Capital 79.06K 13.92K -41.18K 39.29K
Other Non-Cash Items -376.28K 190.87K 628.43K 576.02K
Net Cash From Continuing Operations -537.79K -931.73K 201.71K -2.85M
Net Cash From Discontinued Operations 0.00 0.00 0.00 0.00
Cash Provided By Investing Activities
Net Cash From Total Operating Activities -537.79K -931.73K 201.71K -2.85M
Sale of Property, Plant & Equipment 0.00 0.00 0.00 0.00
Cash Used for Investing Activities
Sale of Short-Term Investments 0.00 0.00 0.00 0.00
Purchases of Property, Plant & Equipment -252.69K -217.17K -76.62K -326.17K
Acquisitions 0.00 0.00 -6.45M 0.00
Purchases of Short-Term Investments 0.00 0.00 0.00 0.00
Other Cash from Investing Activities -995.93K -297.91K -92.44K -143.26K
Cash Provided by Financing Activities
Net Cash From Investing Activities -1.25M -515.08K -6.62M -469.43K
Issuance of Debt 34.78K 1.13M 86.07K 736.57K
Cash Used for Financing Activities
Issuance of Capital Stock 390.35K 0.00 6.95M 4.64M
Repayment of Long-Term Debt 0.00 -21.95K -78.93K -71.97K
Repurchase of Capital Stock 0.00 0.00 0.00 0.00
Payment of Cash Dividends 0.00 0.00 0.00 0.00
Other Financing Charges, Net 0.00 0.00 0.00 -101.00K
Net Cash From Financing Activities 425.13K 1.11M 6.96M 5.20M
Effect of Exchange Rate Changes -121.50K 243.29K -63.82K -55.36K
Net Change in Cash & Cash Equivalents -1.48M -94.75K 472.57K 1.83M
ERB News

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free

ERB ERBA Diagnostics Inc

Chart of ERB

Analysts Ratings for ERB

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy
Moderate Buy
Moderate Sell
Strong Sell

ERB Chatter

Top Rated Stocks Top Rated Funds Top Rated ETFs